InvestorsHub Logo
Followers 231
Posts 34993
Boards Moderated 1
Alias Born 11/19/2003

Re: None

Monday, 04/06/2015 7:13:44 AM

Monday, April 06, 2015 7:13:44 AM

Post# of 955
Curis Announces Orphan Drug Designation for CUDC-907

Company Update (NASDAQ:CRIS): Curis, Inc. Announces Orphan Drug Designation for CUDC-907 in Diffuse Large B-Cell Lymphoma - Smarter Analyst

http://www.smarteranalyst.com/2015/04/06/company-update-nasdaqcris-curis-inc-announces-orphan-drug-designation-cudc-907-diffuse-large-b-cell-lymphoma/

.

.
“It is such a letdown to rise from the dead and have your friends not recognize you.” - Rob Bell, Velvet Elvis
.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRIS News